<DOC>
	<DOCNO>NCT00981500</DOCNO>
	<brief_summary>The investigator wish study effect three form bariatric surgery : Roux-en-Y gastric bypass , Sleeve Gastrectomy , Gastric Banding . The surgery part clinical trial . If insurance cover procedure , responsible payment surgical process . We pre post surgery test provide well understanding effect bariatric surgery-induced weight loss metabolic function .</brief_summary>
	<brief_title>Glucose Homeostasis Pre Post Bariatric Surgery</brief_title>
	<detailed_description>Bariatric surgery effective weight loss therapy obesity . Moreover , early improvement insulin sensitivity resolution type 2 diabetes bariatric surgery lead hypothesis bariatric surgery specific beneficial effect glucose homeostasis beyond weight loss alone . However , hypothesis never adequately evaluated human subject . Therefore , primary goal proposal provide good understanding effect bariatric surgery-induced weight loss insulin action pancreatic beta cell function .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>BMI â‰¥ 35 kg/m2 stable dose medication least 4 week presurgery metabolic study smoke &gt; 7 cigarette per day previous malabsorptive restrictive intestinal surgery pregnant breastfeed recent history neoplasia ( &lt; 5 year ago ) malabsorptive syndrome inflammatory intestinal disease diabetes mellitus show sign oral disease xerostomia ( i.e. , dry mouth ) history chronic rhinitis medication might affect metabolism severe organ dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>obesity</keyword>
	<keyword>gastric bypass</keyword>
	<keyword>gastric banding</keyword>
	<keyword>weight loss</keyword>
	<keyword>insulin sensitivity</keyword>
	<keyword>sleeve gastrectomy</keyword>
	<keyword>fibroblast growth factor 21</keyword>
	<keyword>fibroblast growth factor 19</keyword>
</DOC>